| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |